Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial
Titel:
Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial
Auteur:
Lyke, Kirsten E Berry, Andrea A Mason, Kaitlin Idris, Azza H O'Callahan, Mark Happe, Myra Strom, Larisa Berkowitz, Nina M Guech, Mercy Hu, Zonghui Castro, Mike Basappa, Manjula Wang, Lu Low, Kwang Holman, LaSonji A Mendoza, Floreliz Gordon, Ingelise J Plummer, Sarah H Trofymenko, Olga Strauss, Kathleen S Joshi, Sudhaunshu Shrestha, Biraj Adams, Matthew Chagas, Andrezza Campos Murphy, Jittawadee R Stein, Judy Hickman, Somia McDougal, Andrew Lin, Bob Narpala, Sandeep R Vazquez, Sandra Serebryannyy, Leonid McDermott, Adrian Gaudinski, Martin R Capparelli, Edmund V Coates, Emily E Wu, Richard L Ledgerwood, Julie E Dropulic, Lesia K Seder, Robert A